arrow
A

Aliana Guerrieri-Gonzaga

European Institute of Oncology IRCCS
H指数:34
被引数:3,799

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
Characterization of a Genetic Variant in BARD1 in Subjects Undergoing Germline Testing for Hereditary Tumors

对接受遗传性肿瘤胚系检测的受试者中BARD1基因变异的特征分析

2025-11-180
OAAI
Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study

表观基因组范围甲基化及乳腺癌复发对BRCA基因检测阴性女性的影响:乳腺癌甲基化风险(BREMERI)研究

2025-09-280
OAAI
Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different Approaches

乳腺癌中的胚系检测:一项比较不同方法的优势与挑战的单中心分析

CANCERS
IF4.4
2025-04-240
OA
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules
2024-08-070
PRE
Exemestane and breast cancer prevention: how low can we go? Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative dosing regimen
2024-05-020
PRE
Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials
2024-01-262
OAAI
Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation
2024-01-181
OA
Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized Trial
2023-06-202
OAAI
10-year results of a phase 3 trial of low-dose tamoxifen in non-invasive breast cancer
2023-03-011
PRE
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients

结直肠癌,维生素d和微生物群: 一项针对结直肠癌患者的双盲II期随机试验 (ColoViD)

2022-12-0116
OAAI